Gedea Biotech Ab
Modern, antibiotic free treatment of vaginal infections Founded in 2015 in Lund, Sweden, Gedea Biotech is dedicated to developing safe and effective, antibiotic-free treatments for vaginal infections. Our lead product pHyph is an antibiotic free treatment for bacterial vaginosis that strengthens the healthy vaginal microbiome, supporting good vaginal health also in the long term. pHyph is approved for CE-mark has under EU MDR since 2025. The approval demonstrates the efficacy and safety of pHyph in treating bacterial vaginosis. We want to launch pHyph in partnership with pharmaceutical companies established in women’s health. pHyph is launch ready in Europe and in the US we want to enter a partnership for remaining clinical studies and launch. Gedea is privately held and backed by experienced life science investors. Its lead product pHyph represents a new standard of care in women’s health.
7-day free trial · no credit card
Verified contacts
11
available on Kipplo
LinkedIn employees
16
1 to 10 range
Open roles
—
no listings
Distinct roles
5
indexed titles
Tech stack
3
tools in use
Monthly traffic
3
organic / mo
Sign up free to see all 11 verified contacts at Gedea Biotech Ab
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
11 contacts with verified email or phone · masked until revealed.
Showing 1 of 11 verified contacts
Top roles at Gedea Biotech Ab
5 distinct titles indexed · top 5 shown.
- 3board member
- 1chief financial officer
- 1doctoral researcher
- 1fresenius kabi
- 1project and communications manager
Sign up to unlock all 11 contacts at Gedea Biotech Ab
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 11 verified contacts at Gedea Biotech Ab
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.